Antisolvent crystallisation is a potential technique to prepare engineered lactose with promising aerosolisation properties: effect of saturation degree.
暂无分享,去创建一个
[1] N. Urbanetz,et al. Spray dried mannitol carrier particles with tailored surface properties--the influence of carrier surface roughness and shape. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[2] S. Garnier,et al. Influence of ageing, grinding and preheating on the thermal behaviour of alpha-lactose monohydrate. , 2008, International journal of pharmaceutics.
[3] D. Ganderton. THE GENERATION OF RESPIRABLE CLOUDS FROM COARSE POWDER AGGREGATES , 1992 .
[4] H. Chan,et al. Lactose Composite Carriers for Respiratory Delivery , 2009, Pharmaceutical Research.
[5] H. Chan,et al. The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance. , 2007, Journal of pharmaceutical sciences.
[6] M. Flament,et al. Dry Powder Inhalers: Study of the Parameters Influencing Adhesion and Dispersion of Fluticasone Propionate , 2012, AAPS PharmSciTech.
[7] Waseem Kaialy,et al. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler. , 2010, Colloids and surfaces. B, Biointerfaces.
[8] V. Préat,et al. Comparison of particle sizing techniques in the case of inhalation dry powders. , 2001, Journal of pharmaceutical sciences.
[9] I. Larson,et al. Lactose Surface Modification by Decantation: Are Drug-Fine Lactose Ratios the Key to Better Dispersion of Salmeterol Xinafoate from Lactose-Interactive Mixtures? , 2004, Pharmaceutical Research.
[10] K. Lee,et al. Modeling of Metastable Zone Width Behavior with Dynamic Equation , 2007 .
[11] N. Chew,et al. Effect of powder polydispersity on aerosol generation. , 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[12] Waseem Kaialy,et al. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers. , 2012, Colloids and surfaces. B, Biointerfaces.
[13] P. Young,et al. Does carrier size matter? A fundamental study of drug aerosolisation from carrier based dry powder inhalation systems. , 2011, International journal of pharmaceutics.
[14] F. Podczeck. The relationship between physical properties of lactose monohydrate and the aerodynamic behaviour of adhered drug particles , 1998 .
[15] H. Schulz. Mechanisms and factors affecting intrapulmonary particle deposition: implications for efficient inhalation therapies Holger Schulz , 1998 .
[16] K. Jain,et al. Drug delivery systems - an overview. , 2008, Methods in molecular biology.
[17] S. Dann,et al. Lactose: a definitive guide to polymorph determination. , 2007, International journal of pharmaceutics.
[18] C. Berkland,et al. Combination Chemotherapeutic Dry Powder Aerosols via Controlled Nanoparticle Agglomeration , 2009, Pharmaceutical Research.
[19] Martin J. Donovan,et al. Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations. , 2010, International journal of pharmaceutics.
[20] I. Gonda. STUDY OF THE EFFECTS OF POLYDISPERSITY OF AEROSOLS ON REGIONAL DEPOSITION IN THE RESPIRATORY TRACT , 1981 .
[21] Waseem Kaialy,et al. Influence of lactose carrier particle size on the aerosol performance of budesonide from a dry powder inhaler , 2012 .
[22] Raymond Lau,et al. Inhalation performance of pollen-shape carrier in dry powder formulation: effect of size and surface morphology. , 2011, International journal of pharmaceutics.
[23] R. Langer,et al. Formulation and Physical Characterization of Large Porous Particles for Inhalation , 1999, Pharmaceutical Research.
[24] J. Klein,et al. Particle Size Determination by Laser Reflection: Methodology and problems , 1996 .
[25] P. Royall,et al. Characterisation and Deposition Studies of Recrystallised Lactose from Binary Mixtures of Ethanol/Butanol for Improved Drug Delivery from Dry Powder Inhalers , 2011, The AAPS Journal.
[26] A. Flood,et al. Effect of Growth Rate History on Current Crystal Growth: A Second Look at Surface Effects on Crystal Growth Rates , 2005 .
[27] A. Nokhodchi,et al. Effect of carrier particle shape on dry powder inhaler performance. , 2011, International journal of pharmaceutics.
[28] Christopher Marriott,et al. Particulate Interactions in Dry Powder Formulation , 2013 .
[29] N Lotan,et al. Large porous particles for pulmonary drug delivery. , 1997, Science.
[30] P. Young,et al. The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers. , 2011, International journal of pharmaceutics.
[31] M. Flament,et al. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate. , 2012, International journal of pharmaceutics.
[32] P. Stewart,et al. Particle Interactions Involved in Aerosol Dispersion of Ternary Interactive Mixtures , 2002, Pharmaceutical Research.
[33] K. Amighi,et al. Lactose characteristics and the generation of the aerosol. , 2012, Advanced drug delivery reviews.
[34] L. Harding,et al. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design. , 2009, International journal of pharmaceutics.
[35] Waseem Kaialy,et al. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone. , 2011, Journal of pharmaceutical sciences.
[36] Hartwig Steckel,et al. In vitro evaluation of dry powder inhalers II: influence of carrier particle size and concentration on in vitro deposition , 1997 .
[37] H. Larhrib,et al. Influence of Batch Cooling Crystallization on Mannitol Physical Properties and Drug Dispersion from Dry Powder Inhalers , 2012 .
[38] T. Martonen,et al. Use of Analytically Defined Estimates of Aerosol Respirable Fraction to Predict Lung Deposition Patterns , 1992, Pharmaceutical Research.
[39] Albert H. L. Chow,et al. Particle Engineering for Pulmonary Drug Delivery , 2007, Pharmaceutical Research.
[40] A. Hickey,et al. Drug properties affecting aerosol behavior. , 2000, Respiratory care.
[41] P. Leterme,et al. The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers. , 2004, International journal of pharmaceutics.
[42] M. Ticehurst,et al. The influence of particle physicochemical properties on delivery of drugs by dry powder inhalers to the lung , 2012 .
[43] Waseem Kaialy,et al. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate. , 2012, International journal of pharmaceutics.
[44] Marco Giulietti,et al. Study of lactose crystallization in water‐acetone solutions , 2007 .
[45] M. B. James,et al. The adhesion force of micronized Salmeterol Xinafoate particles to pharmaceutically relevant surface materials , 1996 .
[46] Waseem Kaialy,et al. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient. , 2010, International journal of pharmaceutics.
[47] Waseem Kaialy,et al. The Effect of Engineered Mannitol-Lactose Mixture on Dry Powder Inhaler Performance , 2012, Pharmaceutical Research.